Jingtian & Gongcheng‘s track record covers RMB, USD EUR, HKD, hybrid and offshore funds, including private equity, venture capital, property, hedge, mezzanine and infrastructure funds. The firm is also home to experts in healthcare, energy, media and entertainment-related matters; and its fund establishment experience covers most of China’s provinces, as well as fund establishment such as the US, Cayman, BVI, Hong Kong, Singapore, and Luxembourg. James Yong Wang is a veteran international private equity, venture capital and investment fund specialist, whose experience includes assisting with the design and implementation of offshore and onshore fund and asset management products; and Junlin Bai advises on onshore and offshore investments.
Legal 500 redaktioneller Kommentar

Auszeichnungen

Mandantenzufriedenheit

Kernmandanten

  • China Conch Venture Holdings
  • SK China Company
  • Mercedes-Benz Leasing Co
  • Mercedes-Benz Auto Finance
  • WeBank
  • Joycity Holding Group
  • Stemcor Holdings
  • Univest Securities
  • State Development Investment Corporation
  • Fosun International Securities

Highlight-Mandate

  • Advised Vivo Capital (global biopharmaceutical fund) on the fundraising process for its RMB Medical and Healthcare Industry Fund.
  • Assisted Manulife-sinochem and Suzhou Fund on their investment in Qiming Venture Partners Fund VII, a RMB6.5bn fund that focuses on early-stage healthcare and TMT investments.
  • Assisted Conch Venture with registering a RMB4bn Green Panda bond.

Anwält*innen

Führende Partner*innen

Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.

James Yong Wang

Praxisleitung

James Yong Wang

Weitere Kernanwält*innen

Junlin Bai; Tiancheng He